U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07612605) titled 'Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia' on May 21.
Brief Summary: Through a prospective randomized controlled trial, we systematically evaluate the effects of Yiqi Huoxue Jiedu Formula combined with bacteriophage therapy on the bacterial clearance rate, disease improvement rate and mortality rate in patients with severe pneumonia caused by drug-resistant bacteria, so as to clarify its clinical transformation value.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Pneumonia
Intervention:
DRUG: YHDF placebo
7-14 days treatment with YHDF placebo
DRUG: Bacterioph...